Deoxyribonucleic Acid (DNA)-Based Personalized Nutrition Kit Market Report 2026

The DNA-based personalized nutrition kit market size has grown rapidly in recent years. It will grow from $1.79 billion in 2025 to $2.13 billion in 2026 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to growing consumer interest in personalized nutrition, increasing adoption of direct-to-consumer DNA testing, rising awareness of genetic predispositions to diet-related conditions, expanding availability of affordable genetic testing kits, and growing integration of nutrition insights into wellness programs.

The DNA-based personalized nutrition kit market size is expected to see rapid growth in the next few years. It will grow to $4.23 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to increasing demand for precision health solutions, growing adoption of AI-based nutrition recommendations, rising focus on preventive healthcare, expanding availability of advanced genomic analysis platforms, and increasing consumer shift toward personalized wellness products. Major trends in the forecast period include advancements in bioinformatics and genetic interpretation tools, innovations in multi-omics-based nutrition solutions, development of integrated digital nutrition platforms, research and development in nutrigenomics applications, and the emergence of real-time AI-powered personalized diet planning tools.

The growing consumer interest in personalized health is expected to drive the expansion of the deoxyribonucleic acid (DNA)-based personalized nutrition kit sector in the coming years. Personalized health involves a healthcare and wellness approach that customizes prevention strategies, treatments, nutrition, and lifestyle recommendations based on an individual’s unique traits, including genetic makeup, biomarkers, health history, environment, and behavior, to enhance health outcomes and overall well-being. Advances in genomic sequencing are fueling this increased consumer interest by making genetic insights more accessible, affordable, and practical for everyday health and dietary decisions. DNA-based personalized nutrition kits utilize these advancements by analyzing individual genetic markers to create tailored dietary plans, suggesting specific nutrient intakes and food choices aligned with a person’s metabolic profile. Rising public engagement with genomic research further supports this trend. For example, in January 2025, the National Institutes of Health, a US-based medical research agency, reported that the All of Us Research Program had enrolled over 832,000 participants as of August 24, 2024, with more than 566,000 completing the initial steps of the program. Additionally, the program expanded its researcher workbench data in September 2024, increasing total participants from 413,000 to 633,000, reflecting a 53% growth. Consequently, the increasing consumer interest in personalized health is driving the growth of the deoxyribonucleic acid (DNA)-based personalized nutrition kit sector.

Leading companies in the deoxyribonucleic acid (DNA)-based personalized nutrition kit sector are increasingly emphasizing technological advancements, particularly the creation of sophisticated dietary assessment tools that combine genetic information with real-time food intake tracking. These innovations seek to overcome the limitations of static genetic reports by connecting long-term genetic predispositions with users’ everyday eating habits. By evaluating actual nutritional consumption against genetically tailored dietary requirements, these tools help users identify specific nutrient deficiencies and provide practical, food-based recommendations that can be implemented in daily routines. For example, in October 2025, GenoPalate Inc., a US-based genomic nutrition company, introduced Diet Snapshot, a food frequency questionnaire integrated into its platform. This feature assesses a member’s current diet and compares it with personalized nutritional targets derived from hundreds of genetic variants and lifestyle factors. By pinpointing actionable ways to address nutrient gaps through targeted food choices, the tool improves the personalization of GenoVit multivitamin formulations, ensuring members receive precise nutrient dosages aligned with their biological needs and lifestyle.

In November 2023, Viome Life Sciences Inc., a US-based longevity company focused on microbiome analysis and personalized health solutions, acquired Naring Health Inc. for an undisclosed amount. Through this acquisition, Viome Life Sciences Inc. aimed to expand its personalized nutrition portfolio and reinforce its position in longevity solutions by integrating Naring Health's digital health platforms and molecular data capabilities to enhance its precision diagnostics and supplement offerings. Naring Health Inc. is a US-based digital health and wellness company that delivers individualized clinical and molecular data analysis to support informed health decisions.

Major companies operating in the deoxyribonucleic acid (dna)-based personalized nutrition kit market are 23andMe Inc., Viome Life Sciences Inc., VitaGene Inc., ORIG3N Inc., Helix OpCo Inc., MapmyGenome Pvt. Ltd., DNAlysis Biotechnology, InsideTracker Inc., Nutrigenomix Inc., Pathway Genomics, 3X4 Genetics Inc., FitnessGenes Ltd., Gene by Gene Ltd., Gene Food Inc., Genomelink Inc., GenoPalate Inc., Life X DNA, LifeDNA Inc., myDNA Life Pty Ltd., Xcode Life.

North America was the largest region in the DNA-based personalized nutrition kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna)-based personalized nutrition kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deoxyribonucleic acid (dna)-based personalized nutrition kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the dna-based personalized nutrition kit market by increasing costs of imported reagents, genetic testing equipment, and bioinformatics software. the impact is most pronounced in regions relying on imported kits and components, such as north america and europe, affecting both test kit and analysis service segments. however, tariffs have also encouraged local manufacturing and innovation, allowing companies to develop cost-efficient alternatives and strengthen domestic supply chains, potentially benefiting regional market growth.

DNA-based personalized nutrition kits are consumer health products designed to examine an individual’s genetic information and deliver tailored dietary recommendations. These kits generally consist of DNA collection tools, reagents, and access to bioinformatics platforms that analyze genetic markers associated with nutrition, metabolism, food sensitivities, and overall wellness. They also aid in enhancing dietary planning and promoting better health management.

The primary product types of DNA-based personalized nutrition kits include test kits, analysis services, supplements, and others. Test kits contain sample-collection tools and enable genetic analysis to generate personalized nutrition recommendations. Sample types include saliva, blood, buccal swabs, and others, distributed through online platforms, pharmacies, wellness centers, and others, used in weight management, sports nutrition, digestive health, chronic disease management, and more, by individuals, healthcare professionals, fitness centers, and others.

The deoxyribonucleic acid (DNA)-based personalized nutrition kit market consists of sales of saliva-based DNA collection kits, genetic nutrition testing kits, at-home DNA sampling kits, personalized dietary recommendation kits, and nutrigenomics testing kits. Values in this market are ‘factory gate’ values, meaning the value of goods sold by the manufacturers or creators of these kits, whether to downstream entities (including labs, distributors, retailers, and wellness platforms) or directly to end consumers. The value of goods in this market also includes related services provided by the creators of these kits, such as genetic data processing and personalized nutrition reporting.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.